Cargando…

QS10: The Lysosomal Trafficking Regulator (LYST) Protein is a Novel and Essential Mediator of Cutaneous Wound Healing

PURPOSE: In 2009, chronic wounds were a major public health threat affecting 2% of the population, and the estimated cost of caring for the 6.5 million people in the U.S. with chronic wounds was 50 billion dollars per year [1]. By 2019, 8.2 million people were wound care patients amongst Medicare be...

Descripción completa

Detalles Bibliográficos
Autores principales: Barker, Jenny C., Zbinden, Jacob, Mirhaidari, Gabriel, Blum, Kevin, Breuer, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312784/
http://dx.doi.org/10.1097/01.GOX.0000769984.11154.68
_version_ 1783729199246213120
author Barker, Jenny C.
Zbinden, Jacob
Mirhaidari, Gabriel
Blum, Kevin
Breuer, Christopher
author_facet Barker, Jenny C.
Zbinden, Jacob
Mirhaidari, Gabriel
Blum, Kevin
Breuer, Christopher
author_sort Barker, Jenny C.
collection PubMed
description PURPOSE: In 2009, chronic wounds were a major public health threat affecting 2% of the population, and the estimated cost of caring for the 6.5 million people in the U.S. with chronic wounds was 50 billion dollars per year [1]. By 2019, 8.2 million people were wound care patients amongst Medicare beneficiaries, with a higher cost range for care of 28.1 - 96.8 billion dollars [2]. This prevalence and cost burden highlight the increasing nature of the chronic wound problem. Despite the biologic complexity and phylogenetic conservation, basic understanding of wound biology has been limited to relatively few specific fields of study. Little is known about how entire organelle systems, such as endolysosomal-mediated protein trafficking, regulate cutaneous wound healing. METHODS: We have uncovered a novel and essential regulator of cutaneous wound healing; the Lysosomal Trafficking Regulator (LYST). LYST is a widely expressed gene encoding a protein that regulates intracellular protein trafficking from secretory lysosomes, but the mechanisms underlying its function are unknown. The Beige mouse model possesses a spontaneously occurring mutation in the LYST gene. We utilized a splinted, excisional wound model to characterize wound healing in the Beige mouse to evaluate the role of LYST in normal wound healing. RESULTS: We observed a significant delay to healing (13.7 +/- 1.0 days, C57Bl/6 vs. 16.7 +/- 2.1 days, Beige, p = 0.0098), decreased extracellular matrix (ECM) deposition (60.8 +/- 10.5% collagen density, C57Bl/6 vs. 50.5 +/- 9.9% collagen density, Beige, p = 0.0321), and delayed epithelialization (94.6 +/- 17.1% epithelialized, C57Bl/6 vs. 58.5 +/- 30.0% epithelialized, Beige, p = 0.0044) in Beige wounds. No differences were observed for macrophage infiltration, phenotype or neovascularization. Next, we evaluated protein secretion profiles from primary dermal fibroblasts from Beige and C57Bl/6 mice. Beige fibroblasts demonstrated decreased ability to secrete monocyte chemoattractant protein-1 (MCP-1) (17294 +/- 563 relative optical density (OD), C57Bl/6 vs. 10519 +/- 2348 relative OD, Beige, p = 0.0083) and members of the insulin-like growth factor regulatory axis, IGF-1 and IGFBP2 (IGF-1; 473.8 +/- 40.6 relative OD, C57Bl/6 vs. 149.8 +/- 133.7 relative OD, Beige, p = 0.0159 and IGFBP2; 17918 +/- 664 relative OD, C57Bl/6 vs. 15451 +/- 690 relative OD, Beige, p = 0.0111). While these are known mediators for normal wound healing, specifically, for wound epithelialization and ECM deposition [3-5], the role of LYST in their intracellular protein trafficking and exocytosis has not been previously described. Interestingly, IGF-1 does rely on well-established exocytic pathways reliant on the synaptotagmin family of proteins [6]. These findings, therefore, provide new insight into the intracellular mechanism of action of the LYST protein, which has previously remained elusive. CONCLUSIONS: LYST is important for the secretion of chemokines and growth factors that play an important role in regulating normal wound healing. The expansion of knowledge towards a fundamental understanding of diverse cellular processes involved in normal wound healing, such as endolysosomal trafficking, is important because it provides new lines of investigation for therapeutic strategies to address problem wounds.
format Online
Article
Text
id pubmed-8312784
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-83127842021-07-27 QS10: The Lysosomal Trafficking Regulator (LYST) Protein is a Novel and Essential Mediator of Cutaneous Wound Healing Barker, Jenny C. Zbinden, Jacob Mirhaidari, Gabriel Blum, Kevin Breuer, Christopher Plast Reconstr Surg Glob Open PSRC 2021 Abstract Supplement PURPOSE: In 2009, chronic wounds were a major public health threat affecting 2% of the population, and the estimated cost of caring for the 6.5 million people in the U.S. with chronic wounds was 50 billion dollars per year [1]. By 2019, 8.2 million people were wound care patients amongst Medicare beneficiaries, with a higher cost range for care of 28.1 - 96.8 billion dollars [2]. This prevalence and cost burden highlight the increasing nature of the chronic wound problem. Despite the biologic complexity and phylogenetic conservation, basic understanding of wound biology has been limited to relatively few specific fields of study. Little is known about how entire organelle systems, such as endolysosomal-mediated protein trafficking, regulate cutaneous wound healing. METHODS: We have uncovered a novel and essential regulator of cutaneous wound healing; the Lysosomal Trafficking Regulator (LYST). LYST is a widely expressed gene encoding a protein that regulates intracellular protein trafficking from secretory lysosomes, but the mechanisms underlying its function are unknown. The Beige mouse model possesses a spontaneously occurring mutation in the LYST gene. We utilized a splinted, excisional wound model to characterize wound healing in the Beige mouse to evaluate the role of LYST in normal wound healing. RESULTS: We observed a significant delay to healing (13.7 +/- 1.0 days, C57Bl/6 vs. 16.7 +/- 2.1 days, Beige, p = 0.0098), decreased extracellular matrix (ECM) deposition (60.8 +/- 10.5% collagen density, C57Bl/6 vs. 50.5 +/- 9.9% collagen density, Beige, p = 0.0321), and delayed epithelialization (94.6 +/- 17.1% epithelialized, C57Bl/6 vs. 58.5 +/- 30.0% epithelialized, Beige, p = 0.0044) in Beige wounds. No differences were observed for macrophage infiltration, phenotype or neovascularization. Next, we evaluated protein secretion profiles from primary dermal fibroblasts from Beige and C57Bl/6 mice. Beige fibroblasts demonstrated decreased ability to secrete monocyte chemoattractant protein-1 (MCP-1) (17294 +/- 563 relative optical density (OD), C57Bl/6 vs. 10519 +/- 2348 relative OD, Beige, p = 0.0083) and members of the insulin-like growth factor regulatory axis, IGF-1 and IGFBP2 (IGF-1; 473.8 +/- 40.6 relative OD, C57Bl/6 vs. 149.8 +/- 133.7 relative OD, Beige, p = 0.0159 and IGFBP2; 17918 +/- 664 relative OD, C57Bl/6 vs. 15451 +/- 690 relative OD, Beige, p = 0.0111). While these are known mediators for normal wound healing, specifically, for wound epithelialization and ECM deposition [3-5], the role of LYST in their intracellular protein trafficking and exocytosis has not been previously described. Interestingly, IGF-1 does rely on well-established exocytic pathways reliant on the synaptotagmin family of proteins [6]. These findings, therefore, provide new insight into the intracellular mechanism of action of the LYST protein, which has previously remained elusive. CONCLUSIONS: LYST is important for the secretion of chemokines and growth factors that play an important role in regulating normal wound healing. The expansion of knowledge towards a fundamental understanding of diverse cellular processes involved in normal wound healing, such as endolysosomal trafficking, is important because it provides new lines of investigation for therapeutic strategies to address problem wounds. Lippincott Williams & Wilkins 2021-07-26 /pmc/articles/PMC8312784/ http://dx.doi.org/10.1097/01.GOX.0000769984.11154.68 Text en Copyright © 2021 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle PSRC 2021 Abstract Supplement
Barker, Jenny C.
Zbinden, Jacob
Mirhaidari, Gabriel
Blum, Kevin
Breuer, Christopher
QS10: The Lysosomal Trafficking Regulator (LYST) Protein is a Novel and Essential Mediator of Cutaneous Wound Healing
title QS10: The Lysosomal Trafficking Regulator (LYST) Protein is a Novel and Essential Mediator of Cutaneous Wound Healing
title_full QS10: The Lysosomal Trafficking Regulator (LYST) Protein is a Novel and Essential Mediator of Cutaneous Wound Healing
title_fullStr QS10: The Lysosomal Trafficking Regulator (LYST) Protein is a Novel and Essential Mediator of Cutaneous Wound Healing
title_full_unstemmed QS10: The Lysosomal Trafficking Regulator (LYST) Protein is a Novel and Essential Mediator of Cutaneous Wound Healing
title_short QS10: The Lysosomal Trafficking Regulator (LYST) Protein is a Novel and Essential Mediator of Cutaneous Wound Healing
title_sort qs10: the lysosomal trafficking regulator (lyst) protein is a novel and essential mediator of cutaneous wound healing
topic PSRC 2021 Abstract Supplement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312784/
http://dx.doi.org/10.1097/01.GOX.0000769984.11154.68
work_keys_str_mv AT barkerjennyc qs10thelysosomaltraffickingregulatorlystproteinisanovelandessentialmediatorofcutaneouswoundhealing
AT zbindenjacob qs10thelysosomaltraffickingregulatorlystproteinisanovelandessentialmediatorofcutaneouswoundhealing
AT mirhaidarigabriel qs10thelysosomaltraffickingregulatorlystproteinisanovelandessentialmediatorofcutaneouswoundhealing
AT blumkevin qs10thelysosomaltraffickingregulatorlystproteinisanovelandessentialmediatorofcutaneouswoundhealing
AT breuerchristopher qs10thelysosomaltraffickingregulatorlystproteinisanovelandessentialmediatorofcutaneouswoundhealing